Status:
UNKNOWN
An AI-Based CDSS for Integrated Management of Patients With Acute Ischemic Stroke(GOLDEN BRIDGE II)
Lead Sponsor:
Beijing Tiantan Hospital
Conditions:
Stroke
Eligibility:
All Genders
18-90 years
Phase:
NA
Brief Summary
This study will conduct a cluster randomized controlled trial to evaluate the impact of an artificial intelligence-based clinical decision support system for the integrated management of patients with...
Detailed Description
Artificial intelligence (AI) and clinical decision support system (CDSS) have demonstrated great progress in the diagnosis and treatment of cerebrovascular diseases.CDSS can use computer technology to...
Eligibility Criteria
Inclusion
- Cluster
- Secondary or tertiary hospitals with an emergency department and neurologic wards that receive patients with AIS.
- Hospitals with available brain MRI scans (1.5T or 3.0T).
- Patient
- Patients of 18 years or older.
- Patients admitted with neurological deficit consistent with ischemic stroke within 7 days of of symptoms onset. (\*Symptom onset is defined by the "last seen normal" principle)
- Confirmation of new ischemic stroke by objective modality of CT scan and MRI (had relevant lesions on DWI).
- Informed consent from patient or legally authorised representative (primarily spouse, parents, adult children, otherwise indicated).
Exclusion
- Cluster
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2023
Estimated Enrollment :
21689 Patients enrolled
Trial Details
Trial ID
NCT04524624
Start Date
September 1 2020
End Date
June 30 2023
Last Update
August 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Beijing Tian tan Hospital
Beijing, Beijing Municipality, China, 100070